Pasadena-based Innova Medical Group Inc., which bills itself as the world’s largest manufacturer of rapid antigen tests, announced Monday that it has acquired Pacific PPE Corp., a Pomona company that designs, manufactures and distributes N95 and other face masks for personal protection.
Pacific PPE specializes in the development and manufacturing of ergonomically designed N95 particulate respirators using fully automated processes. The company is currently manufacturing several models, including two CDC NIOSH certified N95 respirator models from its facility in Pomona.
The company is also in the process of preparing to seek FDA clearance to manufacture and market three-ply medical masks in the United States.
Terms of the deal were not announced.
“This acquisition demonstrates Innova’s continued commitment to helping the world fight the COVID-19 pandemic,” said Daniel Elliott, president and CEO of Innova Medical Group. “We are very proud of the quality of 3PE’s products and we are confident that our proven ability to scale production of medical devices will enable these comfortable masks to be available globally at an affordable price point to help protect lives and prevent further spread of COVID-19 and other air-borne viruses causing infectious diseases.”
Innova specializes in screening, testing and diagnostics for cancer, heart disease, arterial calcification, stroke and virus detection focused on infectious disease. In response to the global pandemic, Innova developed rapid diagnostic and screening tests, along with digital reporting and tracing applications, to help organizations manage the COVID-19 crisis.
